MedTrace Logo

JAYDESS Drug Utilization Study in Sweden

NCT02349815 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2023-01-31

No results posted yet for this study

Summary

* To describe characteristics (demographic, clinical, social) of first time users of Jaydess
* To estimate the duration of use of Jaydess
* To study switching patterns, e.g. what are the hormonal contraceptive methods used before and what are the methods after discontinuing Jaydess
* To study off-label use of Jaydess

Conditions

  • Contraception

Interventions

DRUG

Levonorgestrel (Jaydess, Skyla, BAY86-5028)

Women use Levonorgestrel (Jaydess, BAY86-5028) .

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2022-04-01
Completion
2022-04-01

Countries

  • Sweden

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02349815 on ClinicalTrials.gov